International Journal of Infection

Published by: Kowsar

The Prevalence of Hepatitis C Virus Infection in Patients With Thalassemia in Zabol City of Iran

Maysam Yousefi 1 , Mohammad Moein Dehesh 2 , * , Mehrnoosh Ebadi 3 and Azizallah Dehghan 4
Authors Information
1 Assistant Professor of Infectious Disease, Kerman University of Medical Science, Kerman, IR Iran
2 Medical Student, Iranian Medical Students Association of Kerman Local Committee (IMSA), Kerman University of Medical Sciences, Kerman, IR Iran
3 Medical Student, Student Research Committee, Arak University of Medical Sciences, Arak, IR Iran
4 PhD Candidate in Epidemiology, School of Health, Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • International Journal of Infection: January 01, 2017, 4 (1); e37009
  • Published Online: August 3, 2016
  • Article Type: Rapid Communication
  • Received: February 8, 2016
  • Revised: May 11, 2016
  • Accepted: May 11, 2016
  • DOI: 10.17795/iji-37009

To Cite: Yousefi M, Dehesh M M, Ebadi M, Dehghan A. The Prevalence of Hepatitis C Virus Infection in Patients With Thalassemia in Zabol City of Iran, Int J Infect. 2017 ; 4(1):e37009. doi: 10.17795/iji-37009.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Footnotes
References
  • 1. El-Beshlawy A, Youssry I. Prevention of hemoglobinopathies in Egypt. Hemoglobin. 2009; 33: 14-20
  • 2. Vento S, Cainelli F, Cesario F. Infections and thalassaemia. Lancet Infect Dis. 2006; 6(4): 226-33[DOI][PubMed]
  • 3. Alavian SM. Hepatitis C infection in Iran; A review article. Arch Clin Infect Dis. 2009; 4(1): 47-59
  • 4. Brown RJ, Gaglio PJ. Scope of worldwide hepatitis C problem. Liver Transpl. 2003; 9(11)-3[DOI][PubMed]
  • 5. Angelucci E, Pilo F. Treatment of hepatitis C in patients with thalassemia. Haematologica. 2008; 93(8): 1121-3[DOI][PubMed]
  • 6. Ataei B, Hashemipour M, Kassaian N, Hassannejad R, Nokhodian Z, Adibi P. Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran. Int J Prev Med. 2012; 3-23[PubMed]
  • 7. Mohammad Alizadeh AH, Rezazadeh M, Ranjbar M, Fallahian F, Hadjilooi M, Mousavi M, et al. Frequencies of hepatitis B and C infections in hemophiliacs. 2006;
  • 8. Assarehzadegan MA, Ghafourian Boroujerdnia M, Zandian K. Prevalence of hepatitis B and C infections and HCV genotypes among haemophilia patients in ahvaz, southwest iran. Iran Red Crescent Med J. 2012; 14(8): 470-4[PubMed]
  • 9. Mahdaviani F, Saremi S, Rafiei M. Prevalence of hepatitis B, C and HIV infection in thalassemic and hemophilic patients of Markazi province in 2004. 2008;
  • 10. Prevalence of hepatitis B, C and HIV markers in thalassemic and haemophilic patients in Isfahan, Iran, 2004. Vox Sanguinis. : 268
  • 11. Bozorgi SH, Ramezani H, Vahid T, Mostajeri A, Kargar FH, Rezaei M, et al. The prevalence and risk factors of hepatitis C virus infection among thalassemic patients of Qazvin (2005). 2008;
  • 12. Kashanchi LM, Abdolrahim PH. Prevalence of HCV among thalassemia patients in Shahid Bahonar Hospital, Karaj. 2011;
  • 13. Najafi N, Baba M. A study on the Prevalence of chronic Hepatitis C in HCV-Ab positive patients referring to Gaemshahr Razi Hospital clinics in 1998. 2001;
  • 14. Boroujerdnia M, Zadegan M, Zandian K, Rodan M. Prevalence of hepatitis-C virus (HCV) among thalassemia patients in Khuzestan Province, Southwest Iran. Pak J Med Sci Q. 2009; 25: 113-7
  • 15. Azarkar Z, Sharifzadeh G, Chahkandi T, Mahmoudi Rad A, Sandoughi M, Rezaiee N. Survey of HBV and HCV markers in haemodialysis and thalassemia, South Khorasan, Birjand 2007. Sci J Iran Blood Transfus Organ. 2009; 6(3): 233-7
  • 16. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat. 2002; 9(5): 390-2[PubMed]
  • 17. Mishra D, Pensi T. Transfusion associated hepatitis C in multi-transfused thalassemic children. Indian Pediatr. 2004; 41(3): 287-8[PubMed]
  • 18. Marwaha RK, Bansal D, Sharma S, Kumar S, Trehan A, Duseja A, et al. Seroprevalence of hepatitis C and B virus in multiply transfused beta-thalassemics: results from a thalassemic day care unit in north India. Vox Sang. 2003; 85(2): 119-20[PubMed]
  • 19. Jafroodi M, Davoudi-Kiakalayeh A, Mohtasham-Amiri Z, Pourfathollah AA, Haghbin A. Trend in Prevalence of Hepatitis C Virus Infection among beta-thalassemia Major Patients: 10 Years of Experience in Iran. Int J Prev Med. 2015; 6: 89[DOI][PubMed]
  • 20. Valizadeh N, Noroozi M, Hejazi S, Nateghi S, Hashemi A. Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency Viruses among Thalassemia Patients in West North of Iran. Iran J Ped Hematol Oncol. 2015; 5(3): 145-8[PubMed]
  • 21. Esmaeili MR, Mostafazadeh A, Sharbatdarn M, Hajiahmadi M, Alijanpoor M. Hepatitis C in blood products receivers. Iranian J Pediat. 2004; 14(1): 15-20
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments